#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cystic fibrosis Metastases to peritoneum Haemophilia A without inhibitors Spinal cord injury Vitamin B12 deficiency Congenital nephrogenic diabetes insipidus Transitional cell cancer of the renal pelvis and ureter Mantle cell lymphoma refractory Neuroendocrine cell hyperplasia of infancy Congenital cystic kidney disease Chronic myelomonocytic leukaemia Hereditary angioedema with C1 esterase inhibitor deficiency Colon cancer Haemophilia B without inhibitors Macular telangiectasia More trials…

    Learn about Rare Diseases

    Soft tissue sarcoma Soft tissue sarcoma – Trials in Disease Ehlers-Danlos syndrome – Treatment Hereditary neuropathic amyloidosis – Life with Disease Glycogen storage disease type II – Trials in Disease Extranodal marginal zone B-cell lymphoma (MALT type) Mantle cell lymphoma stage II – Trials in Disease Amyotrophic lateral sclerosis Proteus syndrome – Treatment Rosai-Dorfman syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gad20-209-Fsp-A3 Collagenase Anhydrous Glucose Bp Ipn01194 Diroximel Fumarate Bms-986449-03 NIZUBAGLUSTAT Ibuprofen Lysine Ketoprofen Lysine AGALSIDASE BETA STREPTOCOCCUS PYOGENES Clarithromycin Festuca Elatior Pollen Extract Cinnarizine Axatilimab GSKVX000000034795 Vancomycin Nilotinib Anastrozole Mva-209-Fsp-B4 More therapies…

    Learn about Your Condition

    Congenital ureteric anomaly Ocular hypertension Chronic fatigue syndrome Corneal dystrophy Chondrosarcoma metastatic Atrophic vulvovaginitis Primary hypogonadism Pyoderma Nephroblastoma Leiomyosarcoma metastatic Dyspepsia Monogenic diabetes Acute on chronic liver failure Wiskott-Aldrich syndrome Urticaria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Dexamethasone and Fluorometholone for Patients Undergoing Corneal Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Corneal graft failure
    • Corneal graft rejection
    Investigated Drugs:
    • Fluorometholone
    • Dexamethasone
    Germany The Netherlands

  • Study on Immunotherapy with Nivolumab and Ipilimumab for Patients with Early Stage dMMR Rectal Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    Denmark

  • Study on UCPVax, Atezolizumab, and Bevacizumab for Patients with Unresectable Liver Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Ucp4
    • Atezolizumab
    • Bevacizumab
    France

  • Study on Risankizumab for Children Aged 6-17 With Moderate to Severe Plaque Psoriasis After Completing Previous Study

    Recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Risankizumab
    Germany Poland Spain

  • Study Comparing CPX-351 and Chemotherapy for Patients with New Intermediate or High-Risk Acute Myeloid Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Daunorubicin
    • Cytarabine
    • Idarubicin
    France

  • Study on Abatacept for Rheumatoid Arthritis in Patients Responding to Initial TNF Inhibitor Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Abatacept
    France
Previous Page
1 … 568 569 570 571 572 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!